Timeline
biotech
Health & Bio Today: AstraZeneca slides on Bristol Myers merger talk, Edx Medical, BSF Enterprise, Cizzle Biotechnology, genedrive, CelLBxHealth, Coiled Therapeutics, Genflow
AstraZeneca shares fall on reports of Bristol Myers merger talks
Cizzle's US partner adds second lab for lung cancer test
CelLBxHealth study backs Parsortix for ADC target detection
Genflow advances SIRT6 patent portfolio in US and Europe
Coiled Therapeutics doses first patient with new AO-252 formulation
Health & Bio Today: Futura Medical clears EU and UK hurdle for Eroxon Intense, AstraZeneca
AstraZeneca's Datroway wins EU approval for breast cancer
Health & Bio Today: Yarrow Bioscience, Diaceutics, Hemogenyx Pharmaceuticals, Imaging Biometrics, Abingdon Health, Kooth, Allergy Therapeutics
Small Caps Today: Cindrigo restructures Finnish lease, Diaceutics, Hemogenyx, Nichols, Mobico
RTW-backed Yarrow Bioscience goes public via VYNE merger
Imaging Biometrics swings to profit in first half
Diaceutics reports 75% ARR growth in H1 2026 update
Hemogenyx signs Lithuania hospital deal for CAR-T therapy
Allergy Therapeutics guides double digit growth ahead
Health & Bio Today: Oxford BioDynamics lands first Orion deal, NIOX Group, Allergy Therapeutics
Oxford BioDynamics lands first paid deal for Orion platform
Allergy Therapeutics names Helge Weiner-Trapness chairman
Health & Bio Today: Cambridge Cognition grows revenue 16% in H1, AOTI, Tristel, AstraZeneca, Faron Pharmaceuticals
Faron reports encouraging survival data in blood cancer trial
AstraZeneca's Sone-Ve hits survival goal in gastric cancer trial
Health & Bio Today: Scancell to merge with Neuphoria in $89m Nasdaq deal, ProBiotix Health, hVIVO, Creo Medical, AstraZeneca
hVIVO orderbook more than doubles to £65m
Scancell to merge with Neuphoria in Nasdaq listing and $89m financing
ProBiotix strikes Belgian supply deal with Nutrisan
capAI licenses Ageotype platform from R42 for capMedical launch
Health & Bio Today: Tristel confirms full-year growth targets met, Cambridge Raman Imaging, ImmuPharma
Cambridge Raman Imaging wins €400,000 EU grant, eyes pharma quality control
ImmuPharma picks Thermo Fisher for Kapiglucagon manufacturing
Poolbeg wins Israeli patent allowance for POLB 001
Health & Bio Today: Sareum clears toxicology hurdle for psoriasis drug, Advanced Medical Solutions, GSK
Sareum completes toxicology dosing for psoriasis drug candidate
Health & Bio Today: Eli Lilly to acquire AtaiBeckley depression asset, GSK, Thalia Therapeutics
Thalia eyes miRisten data and Sanmirna integration as next milestones
Eli Lilly to acquire Biotech Growth Trust holding AtaiBeckley
Eco Animal Health lifts profit 35% on strong second-half trading
Cizzle Biotechnology gains US accreditation for lung cancer test
CelLBxHealth halves cash burn as Q2 revenue doubles
Health & Bio Today: Poolbeg raises £3.5m for trials, CelLBxHealth, Genus, genedrive, Spire Healthcare, AstraZeneca
AstraZeneca licenses lung cancer drug for up to $1.5bn
Poolbeg Pharma raises £3.5m as executive chair backs placing
Genedrive appoints Graham Cole as new chairperson
CelLBxHealth reaffirms FY2026 revenue target of £2.1 million
The Morning Brief: Rank Group lifts profit outlook, Boohoo Group, Genus, IQE, Capita, Robert Walters
Genus lifts FY26 outlook on stronger second-half trading
Health & Bio Today: Genflow's dog longevity data holds up, Aptamer Group, GSK
Incanthera completes énielle deal, overhauls board
Genedrive performs in line with expectations as adoption of its tests grow
Ixico order book stays 21% above FY25 despite HD programme losses
More in Healthcare
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.